Vigabatrin for the Treatment of Cocaine Dependency
Public ClinicalTrials.gov record NCT01281202. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this 26-28 week study is to demonstrate that the rate of cocaine dependent subjects treated with CPP-109 vigabatrin in addition to counseling, who completely stop use of cocaine in the last 2 weeks of the study's Treatment Phase (Weeks 8 and 9) will be higher than seen in subjects treated with placebo in addition to counseling.
Study identification
- NCT ID
- NCT01281202
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2010
- Primary completion
- Sep 30, 2012
- Completion
- Nov 30, 2012
- Last update posted
- May 17, 2016
2011 – 2012
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Matrix Institute on Addictions | Los Angeles | California | 90016 | — |
| Friends Research Institute | Torrance | California | 90502 | — |
| VA Medical Center | Denver | Colorado | 80220 | — |
| University of Miami School of Medicine | Miami | Florida | 33136 | — |
| NeuroPsychiatric Research & Practice Assoc., Ltd. | Oak Brook | Illinois | 60523 | — |
| Mountain Manor Treatment Center @ Baltimore | Baltimore | Maryland | 21229 | — |
| Boston University School of Medicine | Boston | Massachusetts | 02118 | — |
| Pacific Institute for Research and Evaluation | Albuquerque | New Mexico | 87102 | — |
| Western Psychiatric Inst. and Clinic | Pittsburgh | Pennsylvania | 15213 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29403 | — |
| Pillar Clinical Research, LLC | Dallas | Texas | 75243 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77054 | — |
| George E Wahlen VA Medical Center | Salt Lake City | Utah | 84148 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01281202, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2016 · Synced Sep 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01281202 live on ClinicalTrials.gov.